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Abstract 
 
Motivation: Extraintestinal pathogenic E. coli is the leading cause of urinary tract 
infections and of adult bacteremia. The clonal group STc131 has been identified as the 
primary cause of the global pandemic of multidrug resistance within these E. coli.   
 
Objective: To analyze the diversity of STc131 from a representative sample of isolates of 
phylogroup B2 E. coli that caused bacteremia in the hospital Ramón y Cajal in the last 20 
years. 
 
Material and Methods: Eighty-three E. coli strains, primarily identified as STc131 from 
a representative sample of 528 B2-EC isolates associated with non-duplicated episodes of 
bacteremia in Hospital Ramón y Cajal from the years 1996-2016, were selected for next 
generation sequencing. Bioinformatic techniques were used to annotate the genomes and 
to identify epidemiological markers and mobile genetic elements that may contribute to the 
pathogenic success of particular STc131 clades.   
  
Results: The number of clade C subgroups of STc131 samples isolated from episodes of 
bacteremia in Hospital Ramón y Cajal has increased over the period of collection (1996-
2016), while clade B maintained a stable frequency. Analysis of the accessory genomes of 
these isolates indicate a high degree of diversity between and within the different STc131 
clades.  Less than a quarter (23.7%) of the sample were ESBL positive. 
 
Conclusions. These data indicate the importance of the accessory genome, including the 
plasmid content of the isolates, in the dynamics of this STc131 population with each clade 
having a distinct plasmid, virulence, and antibiotic resistance signature. The results 
highlight diversification of the STc131 before and after the selection by first line antibiotics 
including fluoroquinolones and cephalosporins. 
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1 
 Introduction 
1.1. Motivation of the project 
 
Extra-intestinal pathogenic Escherichia coli (ExPEC)  are  E. coli  able to cause infections 
outside the gastrointestinal system and are the leading cause of urinary tract infections and 
of adult bacteremia1,2. While ExPEC was mostly susceptible to the first line antibiotics that 
are used to treat these infections, such as cephalosporins (cephs) and fluoroquinolones 
(FQs) before the 2000s
2, FQs have become increasingly ineffective in patients throughout 
the world3. The clonal group STc131 has been identified as the primary cause of the global 
pandemic of multidrug resistance of ExPEC4,5. Up to 30% of all ExPEC, 60-90% of FQ-R 
ExPEC and 40-80% of extended spectrum beta lactamase (ESBL) ExPEC belongs to 
STc1316. 
 
The STc131 high-risk clonal complex is subdivided into different genetic groups according 
to the allelic profile of fimH, and the profiles of resistance and virulence (A, B, C0, C1, 
C2)7–10. Clade C2, which is highly associated with the FQ-R and ESBL production of 
STc131, has been globally dominant since the year 20004. Recent papers indicate that the 
origin of Clade C STc131 correlates to the introduction of FQ treatments in the mid-to-late 
1980s, propelled in large part by chromosomal mutations within the gyrA and parC genes 
that confer FQ-R11,12. However, these factors cannot fully explain the global dominance 
clade C has achieved, as other ExPEC strains with similar genetic profiles have not adapted 
to the increasing use of FQ and cephs12 as quickly or as effectively13. 
1.2 Objectives and Focus 
It is likely that mobile genetic elements, such as plasmids and conjugative transposons, 
have contributed to the success of STc131. However the exact mechanisms by which these 
factors contributed to that success remain unclear. Previous studies have shown a clear 
association between clade type and plasmid incompatibility groups14 Notably, plasmids 
associated with  C2 (FII:A1:B replicons) carry beneficial ESBL and virulence factors, such 
as  blaCTX-M-15 and the pemI/pemK addiction system
12,15. When the integration of these 
plasmids occurred and whether it contributed to the diversification of clade C into C1 and 
C2 has not yet been elucidated. 
  
Developing a detailed characterization of clade C STc131 provides a unique opportunity to 
clarify the processes leading to high-risk transmission of antimicrobial resistance and 
virulence in emerging MDR clones. However, the over-representation of sequenced 
genomes of the C2 subgroups and the scarcity of data on the STc131 accessory genome 
have made it difficult to reconstruct the evolutionary history of this polyclonal complex. 
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This project aims to analyze the diversity of STc131 from a representative sample of all 
isolates of E. coli STc131 that caused bacteremia in the hospital Ramón y Cajal in the last 
20 years. 
1.3. Methodology and Work Plan  
In this project NGS technology was used to investigate the roles of MGEs on the fitness of 
STc131 in order to delineate the evolutionary history of this high-risk clone. Bioinformatic 
techniques were used to annotate the genome and to identify genomic islands that may 
contribute to the success of STc131 clade C11. AccNET, an application based on bipartite 
networks developed in our lab, was used to assess the “evolvability” of STc131 clades 
through the analysis of the accessory genome16. Analysis of plasmids to determine 
relationship between plasmid types and STc131 subclades, was performed with Hyasp,  
Mob-Suite, PlasmidFinder, and the CGE pMLST database. Comparison of the Ramón y 
Cajal STc131 samples were compared against NCBI draft genomes of STc131 and non-
STc131 phylogroup B2 E. coli. 
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2 
E. coli STc131, multi-drug resistance, and the role of 
accessory genome on pathogenic success 
2.1. Introduction 
Escherichia coli is categorized into eight recognized phylogroups: A, B1, B2, C, D, E, F, 
and clade I17. Phylogroups A and B1 are most associated with commensal strains, while 
phylogroups B2 and D are associated with ExPEC strains18–20. Phylogroup B2 can be 
divided into 9  subgroups, where the basal subgroup B2-I is demonstrated to have high 
virulence and diversity, and contains the fewest B2 flexible gene pool sequences (set of 
sequences derived from comparative analysis of pathogenic B2 strains to commensal 
phylogroup A strains)21. The clonal group STc131 is a phylogroup B2-I ExPEC strain with 
a high incidence of MDR, shown to express greater resistance and virulence profiles than 
non-STc131 phylogroup B2 MDR strains6,22–24. While STc131 has a robust virulence 
profile, notably certain classical B2 virulence genes are present at low frequency or absent 
in STc131 populations (P fimbria pap genes, cytotoxic necrotizing factor cnf1, haemolysin 
A hlyA, increased serum survival gene iss, and siderophore receptor iroN)
6,9,25. 
2.2. STc131 Clade Diversification 
2.2.1 Differentiating the three clades of STc131 (A, B, and C) 
The three primary clades of the clonal group STc131 can be resolved by FimH typing,  
core-genome multi-locus strain typing (cgMLST), and the presence of FQ-R conferring 
mutations within DNA gyrase subunit A (gyrA) and topoisomerase IV (parC)14,26,27.   
 
The Type 1 fimbrial adhesin FimH is widespread in E. coli and ubiquitous in STc1319. The 
diversity of the FimH gene has emerged as a valuable typing schema within E. coli 
groups28,29. Within STc131, the fimH41 is associated with clade A, fimH22 with clade B, 
and fimH30 with clade C30. Serotyping additionally distinguishes clade A (serotype 
O16:H5) from clades B and C (serotype O25b:H4)13,31. The Pasteur Institute’s cgMLST 
scheme is another typing method that has been shown to be effective at discriminating 
between clonal lineages and can be used to identify subgroups within STc13132–34. In this 
schema, clade A is associated with pST506, clade B with pST9, and clade C with pST43 
and pST62114,35.  
2.2.2. Characteristics of STc131 Clade C 
Gyrase subunit A is a common target of quinolones and mutations within the base range 
67-106 of gyrA, known as the quinolone-resistance determining region (QRDR), have been 
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demonstrated to confer quinolone resistance36,37.  Fluoroquinolone resistance conferring 
point mutations within gyrA (D87N, known as allele gyrA1AB) and parC (S80I and E84V, 
known as allele parC1aAB) further differentiate clade C from the rest of STc13127,30. Clade 
C (fimH30) STc131 with these mutations are known as H30-R, while a smaller subgroup 
of fimH30 STc131 that lack this chromosomal fluoroquinolone resistance are known as 
non-H30-R, or clade C013,38. The existence of clade C0 and genetic homogeneity within 
H30-R support a stepwise evolution model of diversification, wherein H30-R evolved from 
a single strain of fimH30 STc131 that acquired the specific combination of gyrA/parC 
mutations that confer FQ-R38. However, there have also been cases of non-fimH30 STc131 
strains with gyrA/parC FQ-R mutations27. 
 
Clade C is discriminated into two subclades: H30-R (subclade C1) and H30-Rx (subclade 
C2),  where C2 is noted by the association with the blaCTX-M-15 gene
23,27,31,39,40. While CTX-
M-15 is primarily found in C2, it is neither ubiquitous or exclusive to this subclade.  The 
Cefotaximase-Munich41 (CTX-M-) type ESBLs are a group of class A β-lactamases with 
over a hundred variants and the ability to hydrolyze cefotaxime and other extended-
spectrum cephalosporin (ESC)  antimicrobials42,43. While CTX-M-15 is the predominant 
CTX-M-type within STc13144, CTX-M-14 has been associated to a lesser extent with non-
H30 clades and CTX-M-27 has been associated with H30-R subclade C125,38,45. It has been 
recently suggested that subclade C1 should be further subcategorized into C1 and C1-M27, 
to represent the emergent blaCTX-M-27 positive cluster that has been identified in Japan
46. 
2.2.3 Timeline of the Evolution of STc131 
Longitudinal NGS analyses of historical STc13 isolates demonstrate that clade C0 
(acquisition of fimH30 by recombination, acquisition of genomic islands GI-leuX  and GI-
pheV) arose in North America from clade B in the late 1970s/early 1980s. This was 
followed by the development of clade C (acquisition of gyrA/parC FQ-R mutations) in the 
mid/late 1980s, which quickly divided into subclades C1 and C211,12. Thus the emergence 
of FQ-R STc131 coincides with the introduction of second generation quinolone 
(fluoroquinolone) antimicrobials47. It is unknown when subclade C2 acquired the now 
characteristic blaCTX-M-27
 gene, though other studies show that STc131 clade C did not 
become the dominant E. coli lineage until a rapid expansion during the 2000s8,27 and that 
subclade C2 did not become dominant until the late 2000s, indicating that the acquisition 
of the ESBL occurred sometime in this time period40. 
2.3. Success of STc131 Clade C 
The global increase in ESBL producing bacteria over the past decade has been widely 
attributed to STc131 and more recently attributed to subclade C26,25,27,35,48–52. It has been 
suggested that the acquisition of genomic islands such as the virulence-rich GI-pheV (which 
carries several virulence genes including sat and iuta), along with the acquisition of FQ-R 
chromosomal mutations, had primed subclade C2 for success upon acquisition of blaCTX-M-
15
11,38. This is consistent with evidence that STc131 is an exception to the typical “trade-
off” between virulence and antibiotic resistance previously observed at the phylogroup 
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level in E. coli53, as  blaCTX-M-15 positive  STc131 strains have been shown to have high 
colonization ability and lethality in mice models54,55 despite lacking many of the genes 
associated with the virulence potential of phylogroup B256,57. Later studies show extreme 
variability in the lethality of both FQ-R and FQ-S STc131 strains, indicating a  high degree 
of virulence diversity within the clonal group and individual clades57,58. 
2.4. Accessory Genome and Mobile Genetic Elements 
2.4.1 Genomic Islands 
While the acquisition of genomic islands such as GI-pheV  have been identified as key 
events in the differentiation of clade C from the rest of STc13111, this clonal group  lacks 
many of the pathogenicity islands (PAIs) associated with other ExPEC strains55. Of these 
four PAIs (PAI ICFT073, PAI IIJ96, PAI III536, and the Yersinia high-pathogenicity island 
[HPI]), only HPI is highly associated with STc131. However, HPI is not uniquely 
characteristic to STc131 and occurs frequently throughout phylogroup B2 E. coli, studies 
showing that more than 90% of B2 strains contain markers for this island59,60.  Subgroups 
of both clades B (pST9) and C (pST621) have also been identified that are positive for hyla 
and cnf1, markers for PAI IIJ96, however the PAI IIJ96 positive strains paradoxically present 
less lethality in mice models than similar virotypes without this PAI61,58. This indicates that 
a specific combination, or balance, of accessory virulence traits has greater influence on 
the virulence potential of STc131 than the number of virulence genes alone.   
2.4.2 Plasmidome 
The acquisition of different plasmids has been shown to be a key aspect in the variability 
between the resistomes and virulence of STc131 clades and subclades, most notably in the 
expression of  blaCTX-M-15 in C2
12,13,62,63. The incompatibility group F (IncF) family of 
plasmids occur throughout STc131 clades, make up the majority of plasmid types identified 
within STc131 samples, and are associated with the dissemination of ESBL genes within 
the clonal group12,14,64, while non-F incompatibility groups (N, I1/K/BO, I2, A/C, X) 
carrying antibiotic resistance traits are rare in E. coli65. IncF plasmids are a heterogeneous 
group which encompasses a range of sizes (90-140 kb) and replicon types, including  
repFII, repFIA, and repFIB (FAB), which may or may not occur on the same plasmid14,19. 
The allelic variants within the FAB replicons are a common typing scheme for plasmids of 
this type66. 
 
subclade C1 is typically associated with non-blaCTX-M-15 plasmids with the IncF replicon 
sequence type (RST)  FI:A2:B20, while C2 is associated with blaCTX-M-15 positive plasmids 
with either the IncF RST  FII:A1:B-63 or F31:A4:B1/F36:A4:B167. However, it has been 
shown that blaCTX-M-15 is carried within STc131 on a variety of IncF plasmids with a variety 
of replicon sequence types68,69. In subclade C2, the blaCTX-M-15 gene has been shown to 
consistently co-occur with the blaTEM-1, blaOXA-1, the aac(6′)-Ib-cr genes, suggesting a 
common point of origin19 
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3 
Materials and Methods  
 
All software and versions outlined in this section are noted in the Software Appendix at 
the end of this document.  
3.1 Phylogroup B2 E. coli Sample collection and typing 
Eighty-three E. coli (EC) strains, primarily identified as STc131 from a sample of 528 
B2-EC70 isolates representative of 5870 strains associated with non-duplicated episodes 
of bacteremia from the years 1996-2016, were selected for next generation sequencing 
(NGS) with illumina.  
3.2 DNA sequencing,  read processing, genome assembly, and quality 
control 
Total DNA was extracted from 5 mL of overnight cultures using the Wizard Genomic DNA 
Purification Kit (Promega Corp., Madison, WI, USA) and the DNA concentration was 
measured using a Qubit™ Fluorometer and Nanodrop 1000 (Thermo Scientific, Waltham, 
MA, USA). The library preparation was carried out with the Nextera DNA Flex Library 
Prep Kit (Illumina, San Diego, CA). Sequencing was performed using a standard 2 x 100 
or 2 x 150 base protocol in a Genome Analyzer IIx Illumina HiSeq 2500 platform (Illumina, 
San Diego, CA).  
 
The reads were initially processed with Trimmomatic (slidingwindow:5:25 leading:10 
trailing:10 minlen:40) and evaluated for quality with FastQC. The main read statistics of 
the 83 sequence datasets analyzed are shown in Table 1. The trimmed reads were assembled 
using the SPAdes short reads assembler on careful mode using kmer sizes of 27, 33, 39, 
45, 51, and 55. Assembly quality was assessed with Quast and one sample was removed 
(total assembly size smaller than expected of an E. coli genome at 44kb, with N50 and L50 
orders of magnitude smaller than the rest of the sample).  
3.3 Identification of E. coli sequence types and clade diversity 
Genome annotation was performed with Prokka against the Escherichia protein BLAST 
database. Strain typing was performed using the Achtman scheme of multi-locus strain 
typing (MLST) and core genome scheme of multi-locus strain typing (cgMLST). This was 
accomplished through screening of the PubMLST database using Torsten Seeman’s MLST 
software. Non-STc131 assemblies were excluded from further processing. For STc131 
strains, this was followed by fimH-typing (CGE’s fimtyper) and  identification of 
gyrA/parC chromosomal mutations (CGE’s pointfinder) for clade and subclade 
identification.  
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Table 1. Read statistics for 83 phylogroup B2  illumina sequences1
 
1
isolates 1-57 sequenced in 2018 using 2 x 150 protocol, isolates 58-83 processed in 2014 using 2 x 100 protocol 
 
3.4. Core, Accessory and Whole genome analysis 
The alignment and identification of SNPs was performed using Snippy rapid haploid 
variant calling and core genome alignment  of the original reads against an O25b-STc131 
representative genome from Ensembl (IEH71520_1.0), recombination events were filtered 
using Gubbins, and the construction of the core genome maximum likelihood phylogenetic 
tree using IQtree with 100 bootstrap replicates.  
 
Comparison of core, whole, and accessory genome analyses was performed to evaluate the 
diversification of STc131 clades and subclades at different genomic strata. The 73 STc131 
strains used in this analysis were pooled with an additional 25 STc131 isolates (including 
members of clade A and clade C1 positive for blaCTX-M-27) that were also collected at 
Hospital Ramón y Cajal. The accessory genome was analyzed with Accnet, delineating the 
set core and accessory genome products. The accnet data was additionally processed with 
Eggnog Mapper to functionally annotate the accessory genome based on Clusters of 
Orthologous Groups of proteins (COGs), using all orthologs and non-electronic terms to 
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prioritize coverage. The whole genome was analyzed by mash distance, producing a 
distance matrix by Mash pairwise distance calculation on Mash genome sketches with a k-
mer of 27. The SNP core and accessory genome information was converted into distance 
matrices determined by the number of shared traits (common SNPs for core alignment, 
common accessory genes for accessory genome analysis) between every pair of assemblies. 
The resulting distance matrices from the SNP core, whole, and accessory genomes were 
clustered with Mclust and principal component analysis and visualized was performed with 
fviz. We performed hypergeometric testing to determine significant proteins in each 
resulting cluster, adjusting the P-value by the Benjamini-Hochberg procedure to account 
for multiple comparisons.  
 
The construction of the accessory and whole genome phylogenetic trees were constructed 
by neighbor joining using the ape R package. All phylogenetic trees were visualized using 
the iTOL v4. Interactive Tree Of Life web interface.  
3.5. Epidemiological Markers 
The screening (identity 90%, coverage 90%) antibiotic resistance and virulence genes was 
performed using Abricate against the Resfinder databases available at the Center for 
Genome Epidemiology (CGE, www.cge.cbs.dtu.dk) and a repository of known E. coli 
virulence genes (from VFDB, http://www.mgc.ac.cn/VFs/) supplemented with factors 
supported by literature from the Canadian National Microbiology Laboratory 
(https://github.com/phac-nml/ecoli_vf). Visualization of identified pathogenicity islands 
was performed using genoPlotR71. 
3.6. Plasmidome analysis 
Plasmid replicon screening was performed against the PlasmidFinder database with 
abricate software (90% coverage, 90% identity), followed by replicon sequence typing on 
IncF plasmids using the pMLST incF RST database. MOB relaxase and oriT typing was 
performed with MOB-Suite software (90% coverage, 90% identity).  
 
Multiple plasmid reconstruction methods were evaluated, including the MOB-suite plasmid 
reconstruction and Hyasp assembler packages. MOB-suite was used for plasmid assembly 
and typing using the MOB-recon method, which utilizes similarity to clusters of complete 
plasmids to reconstruct plasmids from whole genome data. The HyASP hybrid assembler 
utilizes similarity to discrete plasmid-associated genes (90% identity, 90% coverage 
threshold against the Hyasp database of dereplicated genes of the plasmids obtained from 
NCBI) to identify potential plasmid contigs, followed by the use of factors such as GC% 
to aggregate contigs into plasmid groups (minimum gene density: 0.3, minimum length: 
1500 bases, maximum GC content variability: 0.15). The resulting sets of MOB-suite and 
Hyasp plasmid data were then re-screened for incF replicon sequence type to determine 
any loss of information from these methods. The Hyasp produced plasmid set presented 
worse recall than the MOB-suite plasmid set, with a 20% loss of FAB replicon data between 
the whole genome data and proposed plasmid contigs. Thus, MOB-suite was primarily 
utilized for IncF plasmid reconstruction.   
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 NuRig was used for alignment and visualization of the representative plasmids. 
3.7. NCBI STc131 Dataset Creation and Analysis 
A collection of 797 STc131 draft genomes were curated  from  NCBI. The E. coli 
assemblies from NCBI were first screened by Mash distance to a O25b-STc131 
representative genome from Ensembl (IEH71520_1.0) using the distance cut-off of 0.01 (a 
number observed in our dataset of B2 E. coli to represent a natural division between 
sequence types). The resulting set of assemblies were then verified by MLST typing. The 
dataset underwent a second screening of Mash distance to remove clonal samples, using a 
distance cut-off of 0.0001 to remove redundant genomes. Phylogenetic tree construction 
was performed by neighbor joining with Phylip and visualized using Itol. The resulting 
dataset underwent accessory genome analysis with accnet, screening for virulence and 
antibiotic resistance genes with Abricate against the resfinder and VFDB databases, and 
IncF plasmid replicon typed by pMLST, by the  parameters previously described in this 
section.   
3.8. NCBI Non-STc131 Phylogroup B2 Dataset Creation and Analysis 
A collection of 1709 non-STc131 phylogroup B2 draft genomes were curated  from  NCBI. 
Hierarchal cluster analysis was performed with hclust on the Mash whole genome pairwise 
distance matrix of the E. coli assemblies from NCBI. A range of k values (5-200, step of 
5) were tested for the optimal number of clusters to capture phylogroup B2 samples, 
selecting a value of k=75. The 797 STc131 assemblies were filtered out of the cluster and 
the remaining set of assemblies were then verified by MLST typing. The highest frequency 
MLSTs within this dataset were of known phylogroup B2 sequence types (323 ST95, 264 
ST73, 115 ST13, 92 ST127, 42 ST1193, 30 ST141), while the remainder of the dataset was 
comprised of many low-frequency variants. The NCBI phylogroup B2 dataset then 
underwent a second screening of Mash distance to remove clonal samples, using a distance 
cut-off of 0.0001 to remove redundant genomes. The resulting dataset underwent screening 
for virulence and antibiotic resistance genes with Abricate against the resfinder and VFDB 
databases using previously described parameters.  
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4 
Results 
4.1 STc131 Clade Differentiation 
The 73 STc131 samples were grouped into three main branches corresponding to clade A 
(fimH41 n = 1), clade B (fimH22 n = 13, fimH324 n = 1, fim388 n = 1) and clade C (fimH30 
n = 57, fimH35 n = 1, subgroups C0, C1, C2). Less than a quarter (23.7%) of the strains 
were producers of ESBL (blaCTX-M-15, -14,-27) (Figure 1.A). Two of the clade C samples 
are subcategorized as clade C0 (without the characteristic gyrA and parC chromosomal 
mutations which confer FQ-resistance), 26 were subcategorized as subclade C1 (clade 
containing isolates with blaCTX-M-15) and 29 were subcategorized as subclade C2 (clade 
without blaCTX-M-15 containing isolates). 
 
 
Figure 1. A) Maximum likelihood phylogenetic tree of the 2449 SNPS of the core 
genome of 73 STc131 samples collected between 1996-2017. FimH type 
(H41,H22,H30, and minor subtypes), presence of 3 FQ-R chromosomal mutations 
(gyrA D87N, parC S80I and E84V) and ESBL and closely related genes (blaOXA-
1, aac(6’)-lb) used to categorize  samples into different subclades: A,B,C0, C1, and 
C2. B)  SNP heat map comparing three different STc131 clades. Approximately 
300 SNP distance between clade A and the other two clades, 300 SNP distance 
between clades B and C, 74 SNP distance between clade C0 and the rest of clade 
C, and 30 SNP distance between subclades C1 and C2.  
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4.2 Core, Whole, and Accessory Genome Analysis 
Performing clustering with Mclust on the SNP core genome of the 98 pooled STc131 
isolates (73 from the longitudinal bacteremia study, with 25 additional samples collected 
from Hospital Ramón y Cajal) demonstrates that the assemblies fall within clusters 
consistent with each of the three main STc131 clusters (A, B, and C), where the greatest 
variation occurs between clade A and the other two clades (Figure 2). Within the whole 
genome cluster analysis there is more separation within clades, as clades B and C sort into 
three additional clusters each. Within the whole genome analysis, the greatest variation 
between subclusters occurs within clade B. The accessory genome analysis also sorts  
clades B and C sort into three separate clusters each. The accessory genome analysis 
captures the most variance between subgroups of clade C, where clade C1 comprises one 
cluster and clade C2 separates into two additional groups.  In each of these analyses, clade 
C0 is grouped with either clade C (Core genome) or subclade C1 (accessory and whole 
genome). The blaCTX-M-27 positive subgroup within clade C was not resolved in either whole 
or accessory genome analysis. 
  
 
 
Figure 2. Principal Component Analysis representation of core genome, whole 
genome, and accessory genome STc131 clusters resulting from gaussian mixture 
model clustering on the with Mclust on the SNP alignment, Mash, and accent 
distance matrices respectively.. 
 
 
Of the 8446 accessory genome products identified by ACCNET, 1090 were found to be 
significantly associated (P<0.01) to particular accessory genome clusters, of which 374 
were non-hypothetical products. 59 of these non-hypothetical products were associated 
with clade A clusters, 148 associated with clade B clusters, and 208 to clade C clusters 
(bearing in mind that some products were significantly associated to multiple clusters). The 
significant genome products of the clusters comprising each clade were functionally 
analyzed with Eggnogger (Figure 3.A), as well as the three individual clusters of clade C 
(Figure 3.B). Overall the functional distribution of the accessory genome followed a similar 
pattern regardless of clade, with some exceptions. Notably, within both the clade and sub-
clade analysis, the group considered the most commensal (clade A and sub-clade C1 
respectively) has a strong bias towards proteins associated with carbohydrate transport and 
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metabolism (COG: G) and against proteins of unknown function (COG: S), compared to 
the other groups.    
 
 
Figure 3. A) Percentage of clade associated accessory genome products of each COG 
functional group. B) Percentage of clade C associated accessory genome products of 
each COG functional group by cluster group determined by accnet (here expressed 
related to their corresponding subclades: one cluster within C1, and two clusters 
within C2). 
 
As the accessory genome analysis was found to best represent the diversity within clade 
types, the accnet analysis and clustering was repeated on the 73 longitudinal samples alone. 
With this sample 6 clusters were identified: subclade C1 corresponds to cluster one, 
subclade C2 to clusters three and four, clade B to clusters four, five, and six, while the 
singular clade A isolate also sorted into cluster six.  Of the 6867 accessory genome products 
identified by accnet, 879 were determined to be significantly associated to particular 
accessory genome clusters, of which 282 were non-hypothetical products.  
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4.3 STc131 Epidemiological Markers 
4.3.1 Virulence Profile 
A set of virulence genes/groups (afaA, cdtB, cnf1, hlyA, ibeA, int, iroN, tia, and papC) were 
determined to be significantly associated with the accessory genome clusters (Table 2). 
These genes closely correspond to those previously determined to be markers of different 
STc131 virotypes9,58. Using the Blanco nine virotype schema, our sample contains: 10 
virotype A isolates, 35 virotype C, 2 virotype D1, 3 virotype D2, 4 virotype D3, 4 virotype 
D5, 8 virotype E. Seven isolates displayed combinations of traits that are not accounted for 
by this schema. There were no virotype B isolates in our sample.  
 
The virotype distribution closely aligns with the accessory genome clusters: cluster 1 
associated with virotype C, cluster 2 with virotype A, cluster 3 with virotype E, cluster 4 
with virotypes D1/D2, cluster 5 with virotype D5, and cluster 6 with virotype D3. To reflect 
the grouping observed by accessory genome cluster and virotype within clade C, we 
recategorize cluster 2 of subclade C2 into subclade C2-1 (virotype A) and cluster 3 of 
subclade C2 to subclade C2-2 (virotype E). The hylA/cnf1 fragment of the pathogenicity 
island PAI IIJ96 that differentiates virotypes E and D4 from similar virulence profiles was 
identified in a virotype E isolate (Figure 5). 
 
 
Table 2.  Significant virulence genes by accessory genome cluster 
Cluster Gene Cluster 
Frequency 
Total 
Frequency 
Adjusted P-
Value 
2 afaA 63.60% 12.00% 4.04E-04 
2 afaB-I 63.60% 12.00% 4.04E-04 
2 afaC-I 63.60% 12.00% 4.04E-04 
2 afaD 63.60% 12.00% 4.04E-04 
2 daaF 63.60% 12.00% 4.04E-04 
2 draE2 63.60% 10.70% 4.04E-04 
2 draP 63.60% 12.00% 4.04E-04 
3 cnf1 88.90% 17.30% 3.74E-05 
3 hlyA 100.00% 18.70% 1.46E-06 
3 hlyB 100.00% 18.70% 1.46E-06 
3 hlyC 100.00% 18.70% 1.46E-06 
3 hlyD 100.00% 18.70% 1.46E-06 
3 papC 100.00% 24.00% 2.95E-05 
3 papD 100.00% 28.00% 8.23E-05 
3 papE 100.00% 25.30% 3.74E-05 
3 papF 100.00% 26.70% 5.10E-05 
3 papG 100.00% 14.70% 2.00E-07 
3 papH 100.00% 26.70% 5.10E-05 
3 papJ 100.00% 25.30% 3.74E-05 
3 papK 100.00% 26.70% 5.10E-05 
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4 ibeA 100.00% 17.30% 4.42E-03 
5 cnf1 100.00% 17.30% 5.01E-03 
5 hlyA 100.00% 18.70% 5.19E-03 
5 hlyB 100.00% 18.70% 5.19E-03 
5 hlyC 100.00% 18.70% 5.19E-03 
5 hlyD 100.00% 18.70% 5.19E-03 
5 ibeA 100.00% 17.30% 5.01E-03 
5 iroB 100.00% 12.00% 6.54E-04 
5 iroC 100.00% 12.00% 6.54E-04 
5 iroD 100.00% 12.00% 6.54E-04 
5 iroE 100.00% 12.00% 6.54E-04 
5 iroN 100.00% 12.00% 6.54E-04 
5 papA 100.00% 6.70% 3.11E-05 
 
 
 
Figure 4. Virulence-related genes significantly associated to accessory genome 
clusters and corresponding virotype (A-E) of 73 Ramón y Cajal STc131 samples. 
Novel virotypes denoted as “N”. Phylogenetic tree constructed by neighbor-joining 
method on accnet (accessory genome) distance matrix.  
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Figure 5. Pathogenicity Island (PAI) PIIJ96 fragment from virotype E isolate  
4.3.2. Antibiotic Resistance Genes 
Nearly a quarter of the 73 STc131 isolates contained ESBL genes (n = 18). The majority 
of the ESBL genes identified were blaCTX-M-15 (16 isolates), of which all but one were 
situated within subclade C2. One blaCTX-M-27 was identified within subclade C1, and one 
within blaCTX-M-14 within clade B.  
 
The STc131 clades and subclades additionally have distinct non-ESBL antibiotic resistance 
signatures, identified by those ABR genes determined to be significantly associated to 
accessory genome clusters (Table 3). The resistome of clade C is shown to be more 
extensive than that of clades A and B, containing ABR traits in addition to the ESBL genes 
concentrated in this clade (Figure 6). The antibiotic resistance profiles of the three 
accessory genomes within clade C are distinct but share many similarities. The resistome 
of subclades C1 and C2-1 are nearly identical, apart from the blaCTX-M-15 and the related 
genes (blaOXA-1, aac(61)-lb) found in C2-1.  The resistance profile of subclade C2-2 is also 
highly similar to that of C2-1, but lacks the blaTEM-1B gene and instead contains the aac(3)-
IIa gene. We observe that the blaTEM-1C gene is exclusive to clade B.  
 
Table 3. Significant ABR genes by accessory genome cluster 
Cluster Gene Cluster 
Frequency 
Total 
Frequency 
Adjusted P-
Value 
1 aac(3)-IId_1 27.80% 9.60% 3.68E-04 
1 aadA5_1 55.60% 28.10% 2.44E-04 
1 aph(3'')-Ib_5 33.30% 12.30% 2.44E-04 
1 aph(6)-Id_1 30.60% 12.30% 1.43E-03 
1 blaTEM-1B_1 75.00% 33.30% 2.43E-08 
1 dfrA17_1 55.60% 28.10% 2.44E-04 
1 mdf(A)_1 100.00% 64.00% 5.87E-08 
1 mph(A)_1 52.80% 28.90% 1.56E-03 
1 mph(A)_2 52.80% 28.90% 1.56E-03 
1 sul1_5 58.30% 31.60% 4.84E-04 
1 sul2_2 33.30% 11.40% 6.24E-05 
2 aac(6')-Ib-cr_1 66.70% 14.00% 3.14E-04 
2 blaCTX-M-15_1 66.70% 14.00% 3.14E-04 
2 blaOXA-1_1 66.70% 14.90% 3.82E-04 
2 mph(A)_1 75.00% 28.90% 9.40E-03 
2 mph(A)_2 75.00% 28.90% 9.40E-03 
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3 aac(3)-IIa_1 88.90% 8.80% 2.40E-08 
3 aac(6')-Ib-cr_1 88.90% 14.00% 3.26E-06 
3 blaCTX-M-15_1 77.80% 14.00% 7.13E-05 
3 blaOXA-1_1 88.90% 14.90% 4.07E-06 
5 blaTEM-1C_1 100.00% 7.00% 6.92E-06 
 
Figure 6. Antibiotic resistance genes determined to be significantly associated to accessory 
genome clusters of 73 Ramón y Cajal STc131 samples. Phylogenetic tree constructed by 
neighbor-joining method on accnet (accessory genome) distance matrix.  
4.4 STc131 Plasmidome Analysis 
4.4.1 IncF Plasmid Replicon Typing 
Isolates were screened for incF replicons against the plasmidfinder database, then for 
specific incF FAB allele type against the CGE pMLST database (Figure 7). The sample 
contained 12 distinct FAB allele combinations, associated with specific clades and sub-
clades of STc131.  
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The single clade A isolate contained replicon type of F29:A-:B10. Clade B contained eight 
isolates with replicon type F1:A-:B1, three replicon type F29:A-:B10, one F2:A1:B-. Four 
clade B lacked an FII allele. Subclade C1 contained 19 isolates of replicon type F1:A2:B20, 
five F1:A2:B-, four F4:A2:B20, four F2:A1:B-, one F36:A1:B20, and one F2:A-:B-. 
Subclade C2-1 contained 11 isolates of replicon F2:A1:B-, and one F-:A2:B-. Subclade  
C2-2 was the most homogeneous, containing 4 isolates of type F36:A4:B1 and 5 of type 
F31:A4:B1 (a single point mutation exists between the F31 and F36 alleles). 
 
Subclade C2-2 is the only group of STc131 that showed no plasmid permeability with other 
STc131 clades. There are isolates within both clade A and clade B which contain         
plasmids with F29:A-:B10 replicon sequence types and isolates within clade B and 
subclades C1 and C2-1 which contain plasmids with the replicon sequence type F2:A1:B-.  
Subclade C1 displays the highest IncF replicon variability within the STc131 sample, 
containing five unique RSTs. In two cases the difference between replicon type were 
isolated to the presence/absence of a single FAB replicon (F1:A2:B20 and F1:A2:B-, 
F2:A1:B- and F2:A-:B-).  
 
Figure 7. Allele type for each incF FAB replicon and composite RST for 73 Ramón 
y Cajal STc131 samples. Phylogenetic tree constructed by neighbor-joining method 
on accnet (accessory genome) distance matrix.  
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4.4.2 IncF/MobF Plasmid Extraction 
Of the 15 most frequent MOB-suite plasmid clusters identified within our sample (Figure 
8), we identified the extracted plasmid with the smallest Mash distance to a reference NCBI 
plasmid in that cluster to serve as representative of that plasmid cluster within our sample. 
Seven of these representative plasmids contained both IncF replicon and MobF relaxase 
types (Table 2). Of these IncF/MOBF plasmids, the sizes range from 69.6kb to 138 kb in 
size. We see overlap between 1552 cluster plasmids, which occur in both subclades C1 and 
C2-1.  Alignment of these plasmids shows that the C1-1552 plasmid lacks the characteristic 
blaCTX-M-15 operon of the 1552 plasmid found in subclade C2-1 (Figure 9).  Consistent with 
what was observed in the whole genome virulence and antibiotic resistance screening, 
plasmids associated with clade B (973, 1563) have a more robust virulence signature than 
antibiotic resistance signature, and those associated with clade C have a more robust 
antibiotic resistance signature.  
 
 
Figure 8. Distribution of the 15 most frequent MOB-suite plasmid clusters in 
comparison to the IncF replicon pMLST distribution. Phylogenetic tree constructed 
by neighbor-joining method on accnet (accessory genome) distance matrix 
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Table 4. Resistance genes and virulence determinants in MOBF plasmids. 
Cluster Reference 
Plasmid 
Size 
(kb)  
Rep Antibiotic Resistance 
Genes 
Virulence Genes 
544 KX008967 69.6 IncFIIA 
(F4:A-:B-) 
blaTEM-1B,aadA5, 
dfrA17, mph(A), sul1, 
aph(3'')-Ib 
None-detected 
973 KY007017 134 IncFIB,IncFIIA 
(F2:A-:B1) 
 
None-detected 
iroB,iroC,IroD,iroE
,iroN,iucA,iucB,iuc
C, iucD, iutA 
C1-1552 CP018978 109 IncFIA,IncFIIA 
(F2:A1:B-) 
blaTEM-1B,aadA5, 
dfrA17, mph(A), sul1 
None-detected 
C2-1552 CP013657 138 IncFIA,IncFIIA 
(F2:A1:B-) 
blaTEM-1B,aadA5, 
dfrA17, mph(A), 
sul1,aac(6')-Ib-cr, 
blaCTX-M-15, blaOXA-1 
None-detected 
1554 CP015070 106 IncFIA,IncFIB,IncFIIA 
(F1:A2:B20) 
blaTEM-1B,aadA5, 
dfrA17, mph(A), sul1 
senB 
1555 KP789020 102 IncFIA,IncFIB,IncFIIA 
(F31:A4:B1) 
aac(6')-Ib-cr, blaCTX-M-
15, blaOXA-1,aac(3)-IIa_1 
iutA 
1563 CP012634 110 IncFIB,IncFIIA 
(F29:A-:B10) 
None-detected senB 
 
 
Figure 9. C2_Plasmid_1552 (scaffold, black) alignment with C1_plasmid_1552 
(red), excluding hypothetical protein data. 
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4.5 Hospital Ramón y Cajal STc131 Longitudinal Analysis 
The total number of STc131 isolates identified from the 528 B2-EC strains associated with 
episodes of bacteremia in Hospital Ramon y Cajal has increased relative to the collection 
year (Figure 10). The number of clade B isolates identified has remained consistent over 
the period sampled, however they make up a decreasing proportion of the total STc131 
sample as the population of clade C increased, comprising 75.0% of the sample between 
the years 1996-2004, 17.2% between the years 2005-2010, and 6.45% between the years 
2011-2016. The earliest subclade C1 identified was collected in the year 2000, the earliest 
subclade C2-1 isolate was collected in the year 2005, and the earliest subclade C2-2 isolate 
three years later in 2008. subclade C1 has been the dominant subgroup of STc131 since the 
year 2005 (48.3% of the sample 2005-2010 and 60.6% of the sample 2011-2016). 
 
 
Figure 10. Clade distribution of strains collected between the years of 1996 and 
2016 
4.6 NCBI STc131 
4.6.1 NCBI STc131 Accessory Genome Analysis 
The accessory genome delineated by ACCNET analysis of the 797 STc131 assemblies 
curated from the NCBI database grouped into nine distinct clusters, compared to the seven 
clusters of the 98 Hospital Ramón y Cajal sample. In the NCBI dataset, Clade A sorted into 
one ACCNET cluster, clade B sorted into two clusters, subclade C1 sorted into 3 main 
clusters, and C2 sorted into two clusters. One cluster (cluster 2) spans both subclades C1 
and C2, though is primarily associated with C2 (71.0% of the cluster is associated with this 
subclade). Unlike the Ramón y Cajal sample, the blaCTX-M-15 subgroup of subclade C1 was 
resolved by the accessory genome cluster analysis (Figure 11).  
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Figure 11. Virulence-related genes significantly associated to accessory genome of 
797 NCBI STc131 samples  (excluding those which occurred in fewer than 20 
samples). Phylogenetic tree constructed by neighbor-joining method on ACCNET 
(accessory genome)  distance matrix.  
 
4.6.2 NCBI STc131 Virulence Profile 
The NCBI STc131 assemblies contained significantly fewer (p<0.01) genes from the 
Virulence Factor Database (average of 180.8 virulence genes) than the non-STc131 
phylogroup B2 NCBI dataset (average of 215.6).  
 
A set of virulence genes/groups (afaA, ibeA, iroN, traJ, cdtB, cnf1, hlyA, int, tia, papC, and 
three  hypothetical proteins: ECP_2814, EC958_3095, EC598_5138) were determined to 
be significant (p<0.01) within the accessory genome clusters of the NCBI STc131 using 
hypergeometric testing (Figure 11). The ECP_2814 and EC958_3095 genes are proposed 
to be type VI secretion system related, involved in association to host cell types72–74, while 
EC598_5138 is proposed to be Cah calcium-binding autotransporter related, involved in 
autoaggregation and biofilm formation75.  
 
Virotype C is most frequent virulence profile (483 assemblies), making up the majority of 
Clade A, subclade C1, subclade C-M27, and a large proportion of subclade C2 (Figure 12). 
Of the 266 subclade C2 assemblies 42.1% are also virotype C, in contrast to the Ramón y 
Cajal sample in which only 14.3% of subclade C2 samples are virotype C. There are 110 
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assemblies with virulence profiles that do not fall within the Blanco virotype schema, 71 
virotype D (55.4% of these virotype D3), 61 virotype A, 60 virotype E, and 8 virotype B.  
Of the subclade C2 accessory genome clusters, cluster 8 is closely associated with virotype 
E, while cluster 3 is associated with both virotypes A and C. Accnet cluster 2, which spans 
both subclades C1 and C2, is associated with all three Clade C virotypes: A, C, and E. The 
group of virotype E isolates with higher genomic similarity are reclassified here as subclade 
C2-2. 
 
 
Figure 12.  Neighbor joining tree from Mash distance matrix on 797 STc131 draft 
genomes curated from the NCBI database, Blanco virotypes compared against 
accessory genome clusters. 
4.6.3 NCBI STc131 Antibiotic Resistance Genes 
Antibiotic resistance genes within the NCBI STc131 sample were screened against the 
resfinder database. The NCBI STc131 assemblies contained significantly more (p<0.01) 
antibiotic resistance associated genes (average of 7.42 genes) than the non-STc131 
phylogroup B2 dataset (average of 2.58).  While 23.7% of the Ramón y Cajal STc131 
sample and 47.2% of the NCBI STc131 assemblies are ESBL positive, only 2.8% of the 
non-STc131 phylogroup B2 dataset contained an ESBL.  
 
Of the ESBL positive NCBI STc131, 83.4% of the 221 assemblies which contained blaCTX-
M-15 were within subclade C2, 79.6% of the 98 assemblies which contained blaCTX-M-27 were 
within subclade C-M27, and 76.6% of the assemblies which contained blaCTX-M-14 were 
within subclade C1.  While 93.8% of the Ramón y Cajal blaCTX-M-15 positive samples also 
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presented with the commonly-associated blaOXA1 and aac(6')-Ib-cr genes, only 69.2% of 
the NCBI blaCTX-M-15 positive samples contained both blaOXA1 and aac(6')-Ib-cr.  
 
In addition to the ESBL and ESBL-associated genes other antibiotic resistance genes were 
identified as significantly associated (p<0.01) to particular accessory genome clusters (sul1, 
tet(a), blaTEM-1B, dfrA17, mph(A), aadA5, aph(6’)-ld, aph(3”)-lb, sul2, aac(3)-lla_1, tet(B), 
aad12, dfrA12, dfrA14, blaKPC-2, cmlA) (Figure 13). Within these antibiotic resistance traits, 
clade B has the least robust antibiotic resistance profile and clade A and subclade C1 share 
a robust resistance profile comprised of sul1, sul2, dfrA17, aadA5, mph(A), aph(6’)-ld, 
aph(3”)-lb, tet(A) and blaTEM-1B. The C-M27 subclade of C1 has a similar profile, with the 
blaCTX-M-27 β-lactamase in the place of the blaTEM-1B β-lactamase. The blaCTX-M-15 positive 
subclade C2 also generally lacks the blaTEM-1B β-lactamase, along with the aph(6’)-ld, 
aph(3”)-lb, and sul2.  
 
 
Figure 13. Neighbor joining tree from Mash distance matrix on 797 STc131 draft 
genomes curated from the NCBI database, representing accessory genome clusters 
and significant antibiotic resistance traits (excluding those which occurred in fewer 
than 20 samples). 
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4.6.4 NCBI STc131 Replicon Sequence Type 
The NCBI STc131 has a wide diversity of IncF replicon sequence types with 28 distinct 
FAB allele combinations. Some of these alleles differ by very few nucleotides, such as F36 
and F105 which each differ from F31 by one point mutation. Here we see that the incF 
plasmid RSTs are largely clade and subclade specific: subclades C1 and C2 are each closely 
associated with ten distinct replicon sequence types, while Clades A and B each contain 
three to four unique RSTs specific to their clade in addition to two RSTs (F29:A-:B10, 
F4:A-:B10)  that span between them (Figure 14). There are also instances of permeability 
which are generally unidirectional: there are smaller clusters subclade C1 isolates with 
RSTs largely associated with subclade C2 (F2:A1:B1, F31:A4:B1) and both clade A and 
subclade C2 contains clusters of isolates with RSTs largely associated with subclade C1 
(F1:A2:B20 and F-:A2:B20, respectively). 
 
While in the Hospital Ramón y Cajal samples, the subclade C2-2 isolates (those that had 
acquired the pathogenicity island PAI IIJ96) were associated with incF plasmids of a distinct 
RST (F31/36:A4:B1), however within the NCBI STc131 samples the C2-2 subclade 
contains a wider variety of RSTs. These include the F31/36:A4:B1 RST, in addition to 
F2:A1:B- and F-:A2:B20.  
 
 
Figure 14. Neighbor joining tree from Mash distance matrix on 797 STc131 draft 
genomes curated from the NCBI database, representing IncF plasmid replicon 
allele-type, showing only first perfect hit (100% identity, 100% coverage) in cases 
where multiple copies of IncF FAB replicons were found. 
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5 
Conclusions and Future Directions 
 
Using accent to delineate the accessory genome of the different Ramón y Cajal STc131 
clades and subclades, as well as machine learning techniques such as clustering to analyze 
these relationships, reveals important information on the diversification within this clonal 
group. One such insight is the distinction of the clade C the accessory genome from the rest 
of STc131, with the highest proportion of genome products that are specific to the clusters 
identified within the clade. We see that the accessory genomes of clades B and C have a 
higher density of genome products related to replication, recombination and repair than 
clade A, which is consistent with the presence of elements related to MGE and increased 
accessory genome diversity, as well as many more products of unknown function. The 
accessory genome analysis also indicates that within STc131 there are cases where intra-
clade variance rivals inter-clade variance: showing high separation between the accessory 
genome clusters within both clades B and C, as well as identifying accessory genome 
profiles that spanned multiple clades within the NCBI STc131 dataset.  
 
The accessory genome clusters closely align with the distribution of the IncF plasmid RSTs, 
emphasizing the importance of  IncF plasmids on the plasmidome of STc131 E. coli and 
on the accessory genome of this clonal group as a whole. Clades and subclades of STc131 
are associated with specific plasmids and plasmid replicon sequence types, however there 
is varying degrees of flexibility and permeability between certain clades and for certain 
plasmids. Both the Ramón y Cajal sample and NCBI STc131 dataset show overlap in IncF 
replicon sequence type between subclades C1 and C2. This was reflected in the high 
similarity between F2:A1:B- plasmids identified within samples of  both subclades, the 
composition of which differed primarily in the presence/absence of the CTX-M-15 
antibiotic resistance cassette. The mosaicism of the incF plasmids is also displayed here, as 
many of the different RSTs were only distinguished by a change in one FAB replicon.  
 
The identification of genes related to the epidemiology of STc131 and non-STc131 
phylogroup B E. coli support previous understanding that STc131 has a higher frequency 
of antibiotic resistance traits and lower frequency of virulence-related genes compared to 
non-STc131 phylogroup B26,56. However, the NCBI database of E. coli genomes is not 
necessarily representative of E. coli overall, with a bias towards highly studied strains. 
While the proportion of ESBL positive isolates collected in Hospital Ramón y Cajal from 
cases of bacteremia is also greater than in the non-STc131 phylogroup B2 dataset, it is 
almost half that of the NCBI STc131 dataset. The continued dominance of subclade C1 
within the Ramón y Cajal STc131 sample through time, when it lacks the ESBL genes of 
subclade C2 as well as many of the virulence-related genes of clade B, highlights that other 
factors are important for the dissemination and persistence of STc131 subgroups. 
 
All these data indicate the importance of the accessory genome, including the plasmid 
content of the isolates, in the dynamics of this STc131 population with each clade having 
a distinct plasmid, virulence, and antibiotic resistance signature. However, within the 
individual categories (plasmid content, virulence-related genes, antibiotic resistance genes) 
the boundaries between the clades are not absolute and we identify several points of overlap 
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for particular subclusters. These soft boundaries may contribute to the success of STc131 
by balancing the specializations within the different clades with a degree of flexibility 
between them. Future steps include the reconstruction of a larger number set of 
plasmidomes to better delineate the relationships between clades, to identify the 
characteristics that determine which IncF plasmids are shared between clades or restricted 
to one, and the analysis  of non-IncF plasmids such as Col plasmids which are associated 
with virulence potential of E. coli76,   
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Software Appendix  
Software Version Source 
Python 3.6.7 Python programming language version 3.6.7 available at: https://www.python.org/ 
Perl v5.26.1 Perl programming language version v5.26.1 available at: https://www.perl.org/ 
RStudio 3.4.4 RStudio: Integrated Development for R v3.4.4 available at: http://www.rstudio.com/ 
FastQC 0.11.5 FastQC: a quality control tool for high throughput sequence data v0.11.5  available 
at: http://www.bioinformatics.babraham.ac.uk/projects/fastqc 
Trimmomatic 0.38 Bolger, A. M. et al. Trimmomatic: a flexible trimmer for Illumina sequence data. 
Bioinformatics 30, 2114–2120 (2014). 
SPAdes v3.13.0 Bankevich, A. et al. SPAdes: A New Genome Assembly Algorithm and Its 
Applications to Single-Cell Sequencing. J Comput Biol 19, 455–477 (2012). 
Quast v5.0.1 Gurevich, A. et al. QUAST: quality assessment tool for genome assemblies. 
Bioinformatics 29, 1072–1075 (2013). 
MLST 2.15.2 Torsten Seemann, mlst (2019) GitHub repository, https://github.com/tseemann/mlst 
FimTyper 1.0 Camacho, C. et al. BLAST+: architecture and applications. BMC Bioinformatics 10, 
421 (2009).  
PointFinder 2.0 Zankari, E. et al. PointFinder: a novel web tool for WGS-based detection of 
antimicrobial resistance associated with chromosomal point mutations in bacterial 
pathogens. J Antimicrob Chemother 72, 2764–2768 (2017). 
Snippy 4.3.6 Torsten Seemann, Snippy (2019) GitHub repository, 
https://github.com/tseemann/snippy 
Gubbins 2.3.1-1 Croucher N. J. et al. "Rapid phylogenetic analysis of large samples of recombinant 
bacterial whole genome sequences using Gubbins". Nucleic Acids Research (2014).  
IQtree 1.6.1 Nguyen, L.-T. et al. Q. IQ-TREE: A Fast and Effective Stochastic Algorithm for 
Estimating Maximum-Likelihood Phylogenies. Mol Biol Evol 32, 268–274 (2015). 
Phylip v3.696  Chernomor, O. et al. Terrace Aware Data Structure for Phylogenomic Inference 
from Supermatrices. Syst Biol 65, 997–1008 (2016). 
Mash v2.1 Ondov, B. D. et al. Mash: fast genome and metagenome distance estimation using 
MinHash. Genome Biology 17, 132 (2016). 
Accnet 3.0 Val Lanza, Accnet, (2019), GitHub repository, https://github.com/valflanza/accnet 
Eggnog Mapper 2.0 Eggnog Mapper (2019) Github repository, https://github.com/eggnogdb/eggnog-
mapper 
iTOL Interactive 
Tree Of Life web 
V4 Letunic, I. & Bork, P. Interactive Tree of Life (ITOL) v3: An online tool for the 
display and annotation of phylogenetic and other trees. Nucleic Acids Research 44, 
gkw290 (2016). 
pMLST 0.1.0 Carattoli, A. et al. In Silico Detection and Typing of Plasmids using PlasmidFinder 
and Plasmid Multilocus Sequence Typing. Antimicrob Agents Chemother 58, 3895–
3903 (2014). 
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Mob-Suite 1.4.9.1 Robertson, J. & Nash, J. H. E. MOB-suite: software tools for clustering, 
reconstruction and typing of plasmids from draft assemblies. Microbial Genomics 
4, (2018). 
ABRicate 0.8.10 Torsten Seemann, ABRicate (2019) GitHub repository, 
https://github.com/tseemann/abricate 
Hyasp Jan 2019 Müller, R. & Chauve, C. HyAsP, a greedy tool for plasmids identification. 
Bioinformatics (2019).  
NuRig Beta Val Lanza, NuRig, (2018), GitHub repository, https://github.com/valflanza/nurig 
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Glossary of Acronyms and Abbreviations 
 
❖ ABR: Antibiotic Resistance  
❖ Ceph: Cephalosporin 
❖ CGE: Center for Genomic Epidemiology 
❖ cgMLST: Core Genome Multi-Locus Sequence Type 
❖ COG: Clusters of Orthologous Groups of proteins 
❖ EC: Escherichia coli 
❖ ESBL: Extended spectrum beta lactamase 
❖ ExPEC: Extra-intestinal pathogenic Escherichia coli 
❖ FQ: Fluoroquinolone 
❖ FQ-R: Fluoroquinolone Resistant 
❖ FQ-S: Fluoroquinolone Susceptible 
❖ GI: Genomic Island 
❖ H30-R: FimH30, FQ-R STc131. Also referred to as subclade C1 
❖ H30-Rx: FimH30, ESBL positive, FQ-R STc131. Also referred to as subclade C2 
❖ H30-S:  FimH30 Type, FQ-S STc131. Also referred to as Clade C0 
❖ HPI: Yersinia high-pathogenicity island 
❖ IncF: Incompatibility Group F 
❖ MDR: multidrug resistant 
❖ MGE: Mobile Genetic Element 
❖ MLST: Multi-Locus Sequence Type 
❖ NGS: Next Generation Sequencing 
❖ PAI: Pathogenicity island 
❖ pMLST: Plasmid multi-locus sequence type 
❖ QRDR: Quinolone-resistance determining region 
❖ Rep: Replicon 
❖ RST: Replicon Sequence Type 
❖ UTI: Urinary tract infections 
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